CK2B Induces CD8(+) T-Cell Exhaustion through HDAC8-Mediated Epigenetic Reprogramming to Limit the Efficacy of Anti-PD-1 Therapy in Non-Small-Cell Lung Cancer.
CK2B 通过 HDAC8 介导的表观遗传重编程诱导 CD8(+) T 细胞耗竭，从而限制抗 PD-1 疗法在非小细胞肺癌中的疗效
期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202411053
Liu Shaochuan, Ma Shiya, Liu Gen, Hou Lingjie, Guan Yong, Liu Liang, Meng Yuan, Yu Wenwen, Liu Ting, Zhou Li, Yuan Zhiyong, Pang Shuju, Zhang Siyuan, Li Junyi, Ren Xiubao, Sun Qian
